Lipoxin a(4) attenuates microvascular fluid leak during inflammation

Area of Science:

• Inflammation and immunology
• Vascular biology
• Pharmacology

Background:

• Inflammation triggers cytokine release, disrupting the endothelial barrier and causing fluid loss.
• Lipoxins, like lipoxin A(4) (LXA(4)), are anti-inflammatory mediators that promote inflammation resolution.
• LXA(4) is hypothesized to reverse microvascular fluid leak during inflammatory conditions.

Purpose of the Study:

• To investigate the effect of lipoxin A(4) (LXA(4)) on microvascular fluid leak.
• To determine if LXA(4) can reverse increased vascular permeability induced by platelet-activating factor (PAF) and lipopolysaccharide (LPS).

Main Methods:

• Microvascular fluid leak (L(p)) was measured in rat mesenteric venules using micro-cannulation.
• L(p) was assessed under basal conditions, after LXA(4) administration alone, and following induced hyperpermeability with PAF or LPS.
• The impact of LXA(4) on LPS-induced inflammation was evaluated during c-Jun N-terminal kinase inhibition.

Main Results:

• LXA(4) alone slightly increased L(p).
• PAF and LPS significantly increased L(p), indicating hyperpermeability.
• LXA(4) administration significantly reduced L(p) by 66% after PAF and 42% after LPS.
• C-Jun N-terminal kinase inhibition attenuated LXA(4)'s protective effect by 51%.

Conclusions:

• LXA(4) effectively attenuates intravascular volume loss induced by inflammatory mediators PAF and LPS.
• The anti-inflammatory activity of LXA(4) may involve the c-Jun N-terminal kinase signaling pathway.
• LXA(4) demonstrates a potential pharmacological role in managing inflammatory conditions.